Showing 1 - 20 results of 29 for search 'S Oudard', query time: 0.05s
Refine Results
-
1
An Analysis Of Cd-ROM as a Long Term Archiving Solution by Denis Oudard
Published 1992-01-01
Article -
2
Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer by Elise F. Nassif, Constance Thibault, Stéphane Oudard, Jérôme Galon
Published 2021-01-01
Article -
3
-
4
-
5
-
6
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC) by Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, Marco Moreira, Stéphane Oudard, Yann-Alexandre Vano
Published 2021-01-01
Article -
7
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis by Reza Elaidi, Letuan Phan, Delphine Borchiellini, Philippe Barthelemy, Alain Ravaud, Stéphane Oudard, Yann Vano
Published 2020-06-01
Article -
8
Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors by Soumaya Karaki, Marie Anson, Thi Tran, Delphine Giusti, Charlotte Blanc, Stephane Oudard, Eric Tartour
Published 2016-11-01
Article -
9
Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel by Aurore Carrot, Reza-Thierry Elaidi, Olivier Colomban, Denis Maillet, Michel Tod, Benoit You, Stéphane Oudard
Published 2022-02-01
Article -
10
-
11
-
12
Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients. by Yann-Alexandre Vano, Stéphane Oudard, Marie-Agnès By, Pauline Têtu, Constance Thibault, Hail Aboudagga, Florian Scotté, Reza Elaidi
Published 2018-01-01
Article -
13
Cloud thermodynamic phase inferred from merged POLDER and MODIS data by J. Riedi, B. Marchant, S. Platnick, B. A. Baum, F. Thieuleux, C. Oudard, F. Parol, J.-M. Nicolas, P. Dubuisson
Published 2010-12-01
Article -
14
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study by Nicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, Oliver Sartor, Ronald de Wit, Florence Mercier, Christine Geffriaud-Ricouard, Johann de Bono, Stéphane Oudard
Published 2021-03-01
Article -
15
Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit by Adrien Joseph, Audrey Simonaggio, Annabelle Stoclin, Antoine Vieillard-Baron, Guillaume Geri, Stéphane Oudard, Jean-Marie Michot, Olivier Lambotte, Elie Azoulay, Virginie Lemiale
Published 2020-10-01
Article -
16
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer by Alexander Meisel, Ronald de Wit, Stephane Oudard, Oliver Sartor, Frank Stenner-Liewen, Zhenming Shun, Meredith Foster, Ayse Ozatilgan, Mario Eisenberger, Johann S. de Bono
Published 2022-05-01
Article -
17
Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors. by Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean-Pierre Bergerat, Marie-France Poupon, Stéphane Oudard
Published 2012-01-01
Article -
18
High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions. by Sophie Bernichtein, Natascha Pigat, Thierry Capiod, Florence Boutillon, Virginie Verkarre, Philippe Camparo, Mélanie Viltard, Arnaud Méjean, Stéphane Oudard, Jean-Claude Souberbielle, Gérard Friedlander, Vincent Goffin
Published 2015-01-01
Article -
19
Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer by Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Published 2021-09-01
Article -
20
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio
Published 2023-12-01
Article